ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

50-Gene Set Identifies Known Types Of Breast Cancer

February 27, 2009

Young Investigator Grants Available

July 8, 1977

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

Case Western Wins Renewal.

October 5, 2001